<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25159" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Miliary Tuberculosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vohra</surname>
            <given-names>Shekhar</given-names>
          </name>
          <aff>Maharishi Markandeshwar Medical College and Hospital, Solan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dhaliwal</surname>
            <given-names>Harpal S.</given-names>
          </name>
          <aff>Christian Medical College and Hospital, Ludhiana, Punjab, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shekhar Vohra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Harpal Dhaliwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25159.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Miliary tuberculosis is a severe and disseminated form of tuberculosis (TB), a condition arising from&#x000a0;<italic toggle="yes">Mycobacterium tuberculosis</italic>&#x000a0;infection. Miliary TB occurs when the bacteria spread through the bloodstream, affecting multiple organs throughout the body. The term "miliary" is derived from the Latin word "miliarius," meaning resembling millet seeds, describing the characteristic appearance of the tiny tubercular lesions in affected organs.</p>
        <p>Miliary&#x000a0;TB presentations can be complex. Consequently, diagnosis and treatment are challenging. Understanding the tubercular disease process can guide management strategies and improve outcomes.</p>
        <p>This activity for healthcare professionals is designed to improve learners' competence in evaluating and managing miliary TB. Valuable insights will be gained that will enable learners to collaborate effectively with an interprofessional team caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of miliary tuberculosis.</p></list-item><list-item><p>Evaluate&#x000a0;a patient with suspected&#x000a0;miliary tuberculosis and formulate a clinically appropriate diagnostic plan.</p></list-item><list-item><p>Compare the different miliary tuberculosis treatment&#x000a0;regimens&#x000a0;and create a personalized managed strategy for a patient diagnosed with the condition.</p></list-item><list-item><p>Collaborate effectively with the interpersonal team in managing miliary tuberculosis by formulating short- and long-term treatment plans, monitoring and addressing antituberculosis treatment's side effects, and preventing infectious spread within the community.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25159&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25159">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25159.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tuberculosis (TB) is a condition arising from&#x000a0;<italic toggle="yes">Mycobacterium tuberculosis</italic>&#x000a0;(MTB) infection. MTB is transmitted from a person with pulmonary TB (PTB) infection. Droplet nuclei containing the tubercle bacilli are aerosolized by speaking, sneezing, or coughing. The droplets dry quickly, remain in the air for several hours, and may be inhaled by other individuals. Other MTB transmission routes are insignificant.</p>
        <p>The disease most frequently affects the lungs, though up to a third of TB cases involve other organs. The bacterium is an obligate aerobe and thus typically lodges in the highly oxygenated lung regions, the upper lobe and the lower lobe's superior aspect close to the pleura.</p>
        <p>The functional unit of the lungs is the alveolus. The thin alveolar walls are comprised of the capillary endothelium, basement membrane, and alveolar epithelium&#x02014;components of the blood-air barrier that facilitate gas exchange. Alveolar macrophages are cells derived from monocytes, roaming free inside the alveolar lumen. These phagocytic cells are critical to the lung's immunity but also contribute to TB pathophysiology. Pores of Kohn are alveolar wall perforations where microbes and exudates can spread.</p>
        <p>Lung vasculature is comprised of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary arteries: arise from the pulmonary trunk and branch into lobar and segmental arteries in the lung parenchyma; these arteries carry deoxygenated blood into the lungs</p>
          </list-item>
          <list-item>
            <p>Pulmonary veins: carry oxygenated blood from the lungs and back into the heart and arterial circulation</p>
          </list-item>
          <list-item>
            <p>Bronchial arteries: arise from the thoracic aorta and posterior intercostal arteries; these vessels supply the root of the lungs and visceral pleura</p>
          </list-item>
          <list-item>
            <p>Bronchial veins: follow the bronchial arteries and drain into the azygos and hemiazygos veins</p>
          </list-item>
          <list-item>
            <p>Pulmonary lymphatic plexuses: the superficial subpleural lymphatic plexus drains into the bronchopulmonary (hilar) lymph nodes; the deep bronchopulmonary lymphatic plexus drains into the intrinsic pulmonary lymph nodes before emptying into the bronchopulmonary lymph nodes; the tracheobronchial lymph nodes drain the bronchopulmonary lymph nodes and ultimately empty into the right lymphatic and thoracic ducts</p>
          </list-item>
          <list-item>
            <p>Parietal pleura lymphatics: parietal pleural lymphatic vessels drain into the thoracic wall and axillary lymph nodes</p>
          </list-item>
        </list>
        <p>In immunocompromised patients, failure of the immune system to contain the infection enables MTB to spread from the lungs to the other body organs through the vasculature. Disseminated TB is defined as the simultaneous involvement of at least 2 non-contiguous body organs or infection of the blood, bone marrow, or liver. Miliary TB is a potentially fatal, disseminated form of the disease arising from hematogenous tubercle bacilli spread throughout the lungs and other organs.</p>
        <p>The condition results in the formation of millet-seed-sized (1 to 2 mm) tubercular foci. The term "miliary tuberculosis" was first coined by John Jacobus Manget in 1700 while describing a pathological specimen having tiny tubercles resembling millet seeds in appearance. The term originated from the Latin word "<italic toggle="yes">miliarius</italic>," related to the millet seed. Miliary mottling on a chest radiograph is the classical hallmark that supports the diagnosis of miliary TB. Miliary TB is classified as both pulmonary and extrapulmonary TB.<xref ref-type="bibr" rid="article-25159.r1">[1]</xref><xref ref-type="bibr" rid="article-25159.r2">[2]</xref></p>
        <p>See StatPearls' companion topic, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30653">"Tuberculosis,"</ext-link> for a comprehensive discussion of the epidemiology, pathophysiology, evaluation, and management of pulmonary tuberculosis.</p>
      </sec>
      <sec id="article-25159.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>MTB is primarily responsible for TB manifestations in countries where bovine TB has been eradicated. Infected humans serve as a natural MTB reservoir. The organism is a non-spore-forming, non-motile, obligate-aerobic, facultative, catalase-negative, intracellular bacillus. MTB is gram-neutral and may be visualized by Ziehl-Neelsen (ZN) staining. Cell wall mycolic acids impart acid fastness when decolorized with acid-alcohol. Thus, MTB is also known as acid-alcohol-fast-bacillus (AAFB). Other mycobacteria are classified as nontuberculous or atypical mycobacterial organisms.<xref ref-type="bibr" rid="article-25159.r3">[3]</xref></p>
      </sec>
      <sec id="article-25159.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>According to the World Health Organization (WHO) Global Tuberculosis Report, around 10 million people developed TB, and 1.3 million died from the disease globally in 2017.<xref ref-type="bibr" rid="article-25159.r4">[4]</xref>&#x000a0;Most cases are found in the developing world. However, miliary TB's epidemiological patterns continuously change due to the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Immunosuppressant use</p>
          </list-item>
          <list-item>
            <p>Immigration from highly endemic countries</p>
          </list-item>
          <list-item>
            <p>Surge of HIV cases</p>
          </list-item>
          <list-item>
            <p>Alcoholism</p>
          </list-item>
          <list-item>
            <p>Other medical conditions manifesting with immunosuppression, such as diabetes mellitus and chronic kidney disease</p>
          </list-item>
        </list>
        <p>According to the Centers for Disease Control and Prevention, 8920 new TB cases were reported in the United States in 2019.<xref ref-type="bibr" rid="article-25159.r5">[5]</xref>&#x000a0;Miliary TB accounts for about 1% to 2% of all cases of TB and up to 20% of all forms of extrapulmonary TB in immunocompetent individuals.</p>
        <p>Miliary&#x000a0;TB was thought to be a disease of infants and children before antibiotics were widely used. The disease has a bimodal age distribution, with one peak occurring in young adults and adolescents and the other occurring in older individuals. Miliary TB has a slight male preponderance.<xref ref-type="bibr" rid="article-25159.r6">[6]</xref></p>
      </sec>
      <sec id="article-25159.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>MTB infection starts with the lung epithelial macrophages. The organism's replication is initially unchecked, but the T-helper cell response induces macrophages to suppress bacterial proliferation. Failure of cell-mediated immunity in immunocompromised patients results in the organisms reaching the lymphatic ducts through the pulmonary lymphatics. The lymphatic ducts drain into the right side of the heart and the pulmonary arteries. Systemic spread results when infective lung foci seed the pulmonary venous return to the heart, and the bacilli disseminate via the arterial circulation.&#x000a0;</p>
        <p>The immunopathogenic mechanisms underlying miliary TB development are complex and not fully understood. Containment of the bacteria by effector T-cells is likely compromised. The specific cytokines and other immune-regulatory determinants in the host-pathogen interaction are poorly elucidated.</p>
        <p>What is known, however, is that miliary TB is related to lymphohematogenous MTB dissemination from a primary or reactivation focus to various organs. In endemic countries, reinfection can result in miliary TB. Occasionally, miliary TB emerges from simultaneous dormant foci reactivation within previously infected organs.<xref ref-type="bibr" rid="article-25159.r7">[7]</xref></p>
      </sec>
      <sec id="article-25159.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Grossly, miliary TB is characterized by small, punctate, gray to reddish-brown, rounded lesions with more or less uniform size in the lungs and other organs. In immunocompetent individuals, each microscopic TB focus&#x000a0;contains a typical tubercle with central caseation necrosis and tubercle bacilli surrounded by Langhans-type giant cells, epithelioid cells, lymphocytes, and fibrocytes. However, in immunosuppressed individuals, the foci show caseation with tubercle bacilli without granuloma formation. This condition is known as nonreactive miliary TB.<xref ref-type="bibr" rid="article-25159.r8">[8]</xref><xref ref-type="bibr" rid="article-25159.r9">[9]</xref></p>
      </sec>
      <sec id="article-25159.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical features of miliary TB vary widely, depending on the sites mainly involved, and may remain obscure until late in the disease course. Initial symptoms develop gradually and are usually nonspecific, which include constitutional manifestations such as fever, generalized weakness, anorexia, weight loss, and lassitude. Many patients may initially present with productive coughing, difficulty breathing, chest pain, and hemoptysis. Abdominal symptoms such as nausea, vomiting, and abdominal pain are also common in the early stages.</p>
        <p>The most frequent extrapulmonary sites include the lymphatic system, bones, joints, liver, central nervous system (CNS), and adrenal glands. However, virtually any organ system can be infected, and symptoms referrable to organ-specific dysfunction usually appear.&#x000a0;</p>
        <p>Miliary TB has 2 clinical variants with different demographic profiles and presentations: classical acute and cryptic miliary TB. Both conditions require a high index of suspicion for&#x000a0;timely diagnosis and treatment.&#x000a0;</p>
        <p>
<bold>Acute Miliary TB</bold>
</p>
        <p>Individuals with acute miliary TB are generally younger than 40 years. Most patients have a history of subacute or chronic constitutional symptoms and organ-specific manifestations, depending on the site affected by the disease. Evening febrile episodes and night sweats of 1 to 2 weeks duration are classically described, although a patient can have early morning temperature spikes. Other common initial symptoms include nonproductive cough and dyspnea. Some patients may observe hemoptysis. Acute respiratory distress syndrome (ARDS) is a rare, fatal presentation of miliary TB.<xref ref-type="bibr" rid="article-25159.r10">[10]</xref><xref ref-type="bibr" rid="article-25159.r11">[11]</xref></p>
        <p>Abdominal TB occurs following hematogenous spread from a pulmonary focus or by local spread from a gastrointestinal or abdominal source. Abdominal TB can occur as hepatic, intestinal, or peritoneal involvement.<xref ref-type="bibr" rid="article-25159.r12">[12]</xref>&#x000a0;Hepatic&#x000a0;spread presents as right upper quadrant pain, nausea, vomiting, fever, and generalized fatigue. Icterus and hepatosplenomegaly may be seen clinically.<xref ref-type="bibr" rid="article-25159.r13">[13]</xref><xref ref-type="bibr" rid="article-25159.r14">[14]</xref>&#x000a0;Intestinal TB usually manifests with fever, micro- and macronutrient deficiencies, altered bowel habits, and subacute to acute intestinal obstruction. Children with intestinal TB may have failure to thrive.</p>
        <p>TB peritonitis should be suspected in a patient presenting with complaints of fever, fatigue, abdominal pain, and ascites. Sometimes, the presentation may be confused with an acute abdomen. On surgical exploration, miliary tubercles may be found in the omentum and peritoneal surfaces. Biopsy and histopathology will show tuberculous foci.</p>
        <p>Miliary TB can present as overt adrenal insufficiency (Addison disease) at the time of initial presentation or during antitubercular treatment. The manifestations include skin hyperpigmentation, hypotension, hypoglycemia, and electrolyte imbalance.<xref ref-type="bibr" rid="article-25159.r15">[15]</xref>&#x000a0;</p>
        <p>On fundoscopy, the presence of choroid tubercles is pathognomonic of miliary TB. Choroid tubercles commonly occur in children. These pathological structures are bilateral, pale, and gray-white or yellowish lesions, usually less than a quarter of the optic disc's size, located within 2 cm of the optic nerve.<xref ref-type="bibr" rid="article-25159.r16">[16]</xref></p>
        <p>Musculoskeletal&#x000a0;pathology accounts for 10% of extrapulmonary TB cases. The bony site most commonly involved is the spine, manifesting as tubercular spondylitis or Pott spine. On history, patients with Pott spine may have the classic initial TB symptoms such as fever and weight loss. Back pain and tenderness develop insidiously and are&#x000a0;often the earliest clues to spine involvement. Paraplegia, paraparesis, kyphosis, or&#x000a0;scoliosis develop gradually and may cause complete debility late in the illness.</p>
        <p>The joints are the second most frequently involved sites, and septic (tuberculous) arthritis is common. Other musculoskeletal manifestations of miliary TB include osteomyelitis, tenosynovitis, bursitis, and pyomyositis.<xref ref-type="bibr" rid="article-25159.r17">[17]</xref></p>
        <p>Neurological involvement may present as headaches and nuchal rigidity secondary to tubercular meningitis (TBM) with or without tuberculoma formation. TBM has been reported in 10% to 30% of adult patients with miliary TB. Thoracic transverse myelopathy may manifest as sensorimotor abnormalities.<xref ref-type="bibr" rid="article-25159.r18">[18]</xref><xref ref-type="bibr" rid="article-25159.r19">[19]</xref></p>
        <p>Erythematous macules and papules characterize tuberculosis miliaria cutis. These lesions are manifestations of lymphohematogenous MTB spread in the skin.</p>
        <p>Clinically significant cardiac or renal involvement is uncommon. However, miliary TB can cause myocarditis, congestive heart failure, endocarditis, mycotic aneurysms, and acute kidney injury either directly or as a syndromic constellation of multiorgan dysfunction syndrome (MODS).<xref ref-type="bibr" rid="article-25159.r20">[20]</xref></p>
        <p>Miliary TB can present similarly in children and adults. However, chills, night sweats, hemoptysis, and productive cough are less frequently reported in children&#x000a0;than in adults. In contrast,&#x000a0;peripheral lymphadenopathy and hepatosplenomegaly are more common in the pediatric than in the adult population. TBM is more frequently seen in children with miliary TB (20%&#x02013;40%) than in adults (15% to 30%).<xref ref-type="bibr" rid="article-25159.r21">[21]</xref>&#x000a0;Miliary TB develops less frequently in children who have received the Bacillus Calmette-Gu&#x000e9;rin (BCG) vaccination.&#x000a0;</p>
        <p>TB's&#x000a0;clinical presentation in individuals with HIV depends on their CD4+ count. Patients with HIV having a CD4+ count greater than 200 cells/mm experience disease progression similar to immunocompetent individuals. In contrast, people with HIV with a CD4+ count of less than 200 cells/mm develop atypical manifestations of miliary TB, such as cutaneous lesions, intrathoracic lymphadenopathy, and tuberculin anergy. Profound immunosuppression due to any cause is generally associated with atypical TB presentation.<xref ref-type="bibr" rid="article-25159.r22">[22]</xref>&#x000a0;</p>
        <p>
<bold>Cryptic Miliary TB</bold>
</p>
        <p>Most patients with cryptic miliary TB are older than 60 years. The condition may be considered in the differential diagnosis of fever of unknown origin or metastatic carcinoma, as symptoms like fever, progressive weight loss, and general debility can occur without the usual&#x000a0;TB signs and symptoms.&#x000a0;However, mild hepatosplenomegaly is occasionally observed. Patients often have a normal chest radiograph and negative skin tuberculin test, causing a delay in diagnosis.<xref ref-type="bibr" rid="article-25159.r23">[23]</xref><xref ref-type="bibr" rid="article-25159.r24">[24]</xref></p>
        <p>Atypical manifestations of miliary TB can delay the diagnosis.&#x000a0;Such unusual presentations include ARDS, pneumothorax, cytopenia, septic shock, glomerulonephritis, endocarditis, mycotic aortic aneurysm, cholestatic jaundice, and hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion.</p>
      </sec>
      <sec id="article-25159.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosing miliary TB requires a high suspicion index. A multi-pronged approach, comprised of meticulous history taking, thorough physical examination, and radiological and laboratory investigation, is required for timely diagnosis and adequate treatment.&#x000a0;</p>
        <p>
<bold>Laboratory Findings</bold>
</p>
        <p>Hematological changes seen in miliary TB are usually nonspecific. Pancytopenia, anemia, leucopenia, leucocytosis with predominant lymphocytosis, thrombocytopenia, or thrombocytosis may be reported. The most common hematological abnormality encountered in miliary TB is anemia of chronic disease. Elevated acute-phase reactants, particularly erythrocyte sedimentation rate and C-reactive protein, are frequently encountered. Leukaemoid reaction is also described. Thus, miliary TB may also be mistaken for leukemia. Disseminated intravascular coagulation is rare and seen in the setting of MODS and ARDS.<xref ref-type="bibr" rid="article-25159.r25">[25]</xref><xref ref-type="bibr" rid="article-25159.r26">[26]</xref></p>
        <p>Biochemistry panels can be normal or have subtle disturbances. Hyponatremia, secondary to meningeal involvement or abnormal antidiuretic hormone levels, is frequently encountered and is an indicator of neurological damage. Hyperbilirubinemia, hypoalbuminemia (a negative acute-phase reactant), and elevated alkaline phosphatase are also seen. Hypercalcemia, though rare, has also been reported.<xref ref-type="bibr" rid="article-25159.r27">[27]</xref><xref ref-type="bibr" rid="article-25159.r28">[28]</xref></p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>No uniform guidelines exist for diagnosing miliary TB, but the following criteria have been suggested:</p>
        <list list-type="bullet">
          <list-item>
            <p>Clinical presentation consistent with a diagnosis of TB, such as pyrexia with evening temperature rise, weight loss, anorexia, tachycardia, and night sweats of greater than 6 weeks duration responding to antitubercular treatment</p>
          </list-item>
          <list-item>
            <p>Classical miliary pattern on chest radiograph</p>
          </list-item>
          <list-item>
            <p>Bilateral diffuse reticulonodular lung lesions on a background of miliary shadows demonstrable either on plain chest radiograph or high-resolution computed tomography (HRCT)</p>
          </list-item>
          <list-item>
            <p>Microbiological, cytopathological, histopathological, or molecular evidence of TB</p>
          </list-item>
        </list>
        <p>The chest radiograph shows typical miliary mottling, ie, homogenously distributed, discrete, uniform size (1 to 2 mm), and millet-shaped lesions in all lung zones (see&#x000a0;<bold>Image</bold>. Miliary Tuberculosis Radiography). These features are also the radiographic hallmark of miliary TB. However, these&#x000a0;x-ray findings are usually absent in early disease or cryptic TB. HRCT may be advisable in such cases to look for parenchymal lesions. Contrast-enhanced CT (CECT) is preferable for evaluating lymphadenopathy, calcifications, and pleural pathology.<xref ref-type="bibr" rid="article-25159.r29">[29]</xref><xref ref-type="bibr" rid="article-25159.r30">[30]</xref></p>
        <p>Extrapulmonary TB lesions may be assessed by ultrasonography, CECT, and magnetic resonance imaging (MRI), which can determine the extent of organ involvement.<xref ref-type="bibr" rid="article-25159.r31">[31]</xref>&#x000a0;Positron-emission tomographic CT has been recently used as an investigating tool for evaluating patients with suspected TB.<xref ref-type="bibr" rid="article-25159.r32">[32]</xref><xref ref-type="bibr" rid="article-25159.r33">[33]</xref><xref ref-type="bibr" rid="article-25159.r34">[34]</xref></p>
        <p>Invasive diagnostic procedures are indicated for patients with suspected extrapulmonary TB. The following have a good diagnostic yield in miliary TB:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cerebrospinal fluid (CSF)</p>
          </list-item>
          <list-item>
            <p>Pleural fluid</p>
          </list-item>
          <list-item>
            <p>Ascitic fluid</p>
          </list-item>
          <list-item>
            <p>Gastric aspirate</p>
          </list-item>
          <list-item>
            <p>Urine</p>
          </list-item>
          <list-item>
            <p>Pus from a cold abscess</p>
          </list-item>
          <list-item>
            <p>Biopsy and culture of bone marrow and liver tissue&#x000a0;</p>
          </list-item>
        </list>
        <p>Image-guided radiological procedures, such as fine-needle aspiration and tissue biopsy, are useful for procuring tissue and body fluids for diagnostic testing. Ultrasound, CT, and MRI are frequently used in these procedures.<xref ref-type="bibr" rid="article-25159.r35">[35]</xref><xref ref-type="bibr" rid="article-25159.r36">[36]</xref></p>
        <p>
<bold>Immunology-Based Methods</bold>
</p>
        <p>Anergy on tuberculin skin testing (TST) is more frequently reported in miliary TB than PTB, though the test can become positive during antitubercular therapy. A positive interferon-&#x003b3; release assay indicates infection but does not signify active disease. Thus, this diagnostic modality is of limited use in highly endemic areas.<xref ref-type="bibr" rid="article-25159.r37">[37]</xref>&#x000a0;</p>
        <p>Serological tests are not advocated for TB detection because of their low sensitivity and specificity. However, adenosine deaminase (ADA) and interferon-&#x003b3; (IFN-&#x003b3;) may be used as adjuncts for detecting the presence of MTB in pleural, pericardial, and ascitic fluids.<xref ref-type="bibr" rid="article-25159.r38">[38]</xref><xref ref-type="bibr" rid="article-25159.r39">[39]</xref><xref ref-type="bibr" rid="article-25159.r40">[40]</xref><xref ref-type="bibr" rid="article-25159.r41">[41]</xref>&#x000a0;ADA may also be used in diagnosing TBM.<xref ref-type="bibr" rid="article-25159.r42">[42]</xref></p>
        <p>The ADA cutoff value for pleural and pericardial effusion is 40 U/L; for tubercular ascites is 39 U/L; and for CSF is 10 U/L.<xref ref-type="bibr" rid="article-25159.r43">[43]</xref><xref ref-type="bibr" rid="article-25159.r44">[44]</xref><xref ref-type="bibr" rid="article-25159.r45">[45]</xref>&#x000a0;ADA levels may be falsely elevated in the presence of empyema, parapneumonic effusions, endometriosis, malignancies like lymphoma, and collagen vascular disorder.<xref ref-type="bibr" rid="article-25159.r43">[43]</xref>&#x000a0;High CSF ADA can also be seen in cerebral malaria, brucellosis, neurosarcoidosis, fulminant pyogenic meningitis, AIDS, and CSF lymphoma.<xref ref-type="bibr" rid="article-25159.r46">[46]</xref></p>
        <p>
<bold>Molecular Studies</bold>
</p>
        <p>Molecular methods such as polymerase chain reaction, Gene Xpert MTB/RIF, and line probe assays may be useful in the early diagnosis of pulmonary and extrapulmonary TB and in detecting drug-resistant tubercle bacilli. Various tissue specimens may be used, and results may be available within hours.<xref ref-type="bibr" rid="article-25159.r47">[47]</xref><xref ref-type="bibr" rid="article-25159.r48">[48]</xref><xref ref-type="bibr" rid="article-25159.r49">[49]</xref><xref ref-type="bibr" rid="article-25159.r50">[50]</xref></p>
        <p>
<bold>Definitive Diagnosis</bold>
</p>
        <p>Detection of mycobacterial isolates from a clinical specimen provides a definitive diagnosis of disseminated TB. Examples of tissue specimens are sputum, body fluids, tissue, and biopsy samples. The specimens are inoculated on agar-based (eg, Lowenstein-Jensen or LJ) or liquid media with fluorescence detection. Direct visualization of acid-fast bacilli is aided by ZN staining or the more sensitive auramine-rhodamine (fluorochrome dye) staining.<xref ref-type="bibr" rid="article-25159.r51">[51]</xref><xref ref-type="bibr" rid="article-25159.r52">[52]</xref>&#x000a0;The specimen should be cultured on standard solid LJ media and then inoculated in liquid media (eg, BACTEC Mycobacterial Growth Indicator Tube or BACTEC&#x02122; MGIT&#x02122; 960).<xref ref-type="bibr" rid="article-25159.r53">[53]</xref></p>
        <p>Liquid-based media reduces the MTB detection time to 1 to 3 weeks, compared to 6 to 8 weeks on solid media. The method also shortens drug sensitivity testing time.</p>
        <p>Blood culture is usually not employed for mycobacterium isolation. This test is usually negative, although positive results may be reported among immunocompromised individuals with hematogenous dissemination.<xref ref-type="bibr" rid="article-25159.r54">[54]</xref>&#x000a0;MTB may be differentiated from isolated nontuberculous mycobacteria by hybridization using nucleic acid probes or biochemical methods or by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF).<xref ref-type="bibr" rid="article-25159.r55">[55]</xref></p>
        <p>Histopathological examination of a tissue biopsy specimen should show granulomatous inflammation with central caseation, with or without tubercle bacilli. Demonstration of a tubercle granuloma in a biopsy sample obtained from a patient with typical TB manifestations is suggestive of TB. However, demonstration of bacilli by staining or culture is required to confirm the diagnosis.<xref ref-type="bibr" rid="article-25159.r56">[56]</xref></p>
      </sec>
      <sec id="article-25159.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Standard PTB drug regimen may also be used for treating miliary TB. As per the WHO, a standard 6-month antitubercular drug regimen consists of a 2-month intensive or bactericidal phase with isoniazid, rifampicin, pyrazinamide, and ethambutol and a 4-month continuation or sterilizing phase with isoniazid and rifampicin. Treatment duration may be modified according to the age group affected and primary disease site.</p>
        <p>Longer treatment periods are advisable for children, immunocompromised individuals, patients with a slow clinical response, and the presence of TBM, TB lymphadenitis, or skeletal TB. The generally recommended minimum therapeutic duration is 9 months for skeletal TB and 12 months for TBM.<xref ref-type="bibr" rid="article-25159.r57">[57]</xref><xref ref-type="bibr" rid="article-25159.r58">[58]</xref><xref ref-type="bibr" rid="article-25159.r59">[59]</xref></p>
        <p>For abdominal TB, 9 months of therapy used to be the conventional approach. However, a recent multicenter, randomized trial showed that both 6-month and 9-month regimens are equivalent for patients with abdominal TB.<xref ref-type="bibr" rid="article-25159.r60">[60]</xref>&#x000a0;Neurological involvement, particularly TBM, must be determined in all miliary TB cases. Neurologic TB requires a longer treatment duration than the standard and concomitant steroid therapy.<xref ref-type="bibr" rid="article-25159.r61">[61]</xref></p>
        <p>For previously treated patients, the WHO guidelines advocate that culture and drug susceptibility testing (DST) specimens be obtained from all previously treated TB patients at or before the start of treatment. DST should be performed for at least isoniazid and rifampicin. In settings where rapid molecular DSTs are available, the DST results should guide the choice of regimen. The duration of treatment may also be individualized according to the clinical setting.</p>
        <p>Patients suspected of miliary TB must be screened for diabetes mellitus and HIV before initiating antitubercular treatment and vice-versa. Immune reconstitution inflammatory response (IRIS) is a condition arising from excessive immune reaction to MTB that may develop in patients with HIV during or after completing an antitubercular drug regimen. Antiretroviral treatment (ART) for all patients with HIV and TB must not be initiated within the first 8 weeks of starting TB treatment and within 2 weeks in profoundly immunosuppressed HIV-positive TB patients with CD4+ counts less than 50 to prevent IRIS.<xref ref-type="bibr" rid="article-25159.r62">[62]</xref><xref ref-type="bibr" rid="article-25159.r63">[63]</xref></p>
        <p>Medical and surgical interventions may be warranted for diagnosis and therapy. Examples are mechanical ventilation for ARDS, abdominal surgery for small bowel perforation, and ventriculoperitoneal shunt surgery for TBM, which may be performed to reduce TB complications.</p>
        <p>Although substantial evidence is lacking, corticosteroid use in miliary TB has shown clinical efficacy in a few scenarios. Notably, it has been demonstrated to be beneficial in adrenal insufficiency, TB meningitis, large pericardial or pleural effusion, IRIS, ARDS, immune-complex nephritis, and secondary hemophagocytic syndrome.<xref ref-type="bibr" rid="article-25159.r64">[64]</xref><xref ref-type="bibr" rid="article-25159.r65">[65]</xref>&#x000a0;Liver function tests (LFTs) should be obtained before and during anti-TB therapy (ATT). Serial LFTs should be performed to check for ATT-induced hepatitis.</p>
        <p>The criteria for ATT-induced hepatitis have evolved and include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Transaminases are elevated up to 5 times the upper normal limit without hepatitis symptoms; or</p>
          </list-item>
          <list-item>
            <p>Transaminases are elevated up to 3 times the upper normal limit with hepatitis symptoms; or</p>
          </list-item>
          <list-item>
            <p>Bilirubin rises twice the upper normal limit, and other possible hepatitis causes, like acute viral hepatitis and autoimmune hepatitis, have been ruled out.</p>
          </list-item>
        </list>
        <p>All hepatotoxic drugs&#x02014;isoniazid, rifampicin, and pyrazinamide&#x02014;should be withdrawn if ATT-induced hepatitis develops. A modified ATT regimen must be initiated to prevent further liver damage. According to guidelines from the British and American Thoracic Societies, ATT rechallenge may be considered once the LFTs have normalized. The decision to restart ATT drugs at incrementally increasing doses or full doses should be guided by the clinical picture.<xref ref-type="bibr" rid="article-25159.r66">[66]</xref><xref ref-type="bibr" rid="article-25159.r67">[67]</xref></p>
      </sec>
      <sec id="article-25159.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The protean and nonspecific clinical manifestations of miliary TB often generate a large differential diagnosis. The common constitutional symptoms of fever, chills, night sweats, anorexia, weight loss, and fatigue raise concerns about many potential infectious, autoimmune, and neoplastic etiologies. Headache, seizures, altered sensorium, cough, chest pain, hemoptysis, abdominal pain, lymphadenopathy, hepatosplenomegaly, back pain, and neurologic dysfunction are themselves nonspecific manifestations of a huge number of diseases. The manifestations of miliary TB often develop gradually, and their lack of specificity frequently results in a diagnostic delay. However, the constellation of signs and symptoms and patient demographic and immune status must be taken into account when evaluating patients who may have miliary TB.</p>
        <p>Varied clinical etiologies can present with a miliary pattern on chest radiography and CT. Therefore, a thorough workup is required to reach an etiological conclusion. Other causes of miliary shadowing include histoplasmosis, blastomycosis, coccidioidomycosis, nocardiosis, sarcoidosis, lung carcinoma with lymphangitis carcinomatosis, metastatic carcinoma, pyogenic infection spread from a remote site, pulmonary hemosiderosis, and hypersensitivity pneumonitis.<xref ref-type="bibr" rid="article-25159.r68">[68]</xref></p>
      </sec>
      <sec id="article-25159.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Miliary&#x000a0;TB has high morbidity and mortality.&#x000a0;Treatment delay&#x000a0;appears to be the most&#x000a0;significant factor responsible for mortality. The mortality related to miliary TB is approximately&#x000a0;15% to 20 % in children and 25% to 30% in adults.<xref ref-type="bibr" rid="article-25159.r69">[69]</xref><xref ref-type="bibr" rid="article-25159.r70">[70]</xref><xref ref-type="bibr" rid="article-25159.r71">[71]</xref></p>
        <p>In patients with ARDS due to miliary TB, the following Acute Physiology and Chronic Health Evaluation (APACHE II) scores have been identified as mortality predictors:</p>
        <list list-type="bullet">
          <list-item>
            <p>Greater than 18</p>
          </list-item>
          <list-item>
            <p>Less than or equal to 18&#x000a0;with hyponatremia and a ratio of arterial oxygen tension to the fraction of inspired oxygen (FiO2) less than or equal to 108.5&#x000a0;<xref ref-type="bibr" rid="article-25159.r72">[72]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25159.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Delayed treatment of miliary TB can&#x000a0;produce the following emergent complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>MODS</p>
          </list-item>
          <list-item>
            <p>Tubercular empyema</p>
          </list-item>
          <list-item>
            <p>The air leak syndromes pneumothorax and pneumomediastinum</p>
          </list-item>
          <list-item>
            <p>Tubercular pericardial effusion and pericarditis</p>
          </list-item>
          <list-item>
            <p>Immune reconstitution inflammatory syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Myocarditis, native and prosthetic valve endocarditis, and intracardiac masses</p>
          </list-item>
          <list-item>
            <p>Mycotic aneurysm of the aorta</p>
          </list-item>
          <list-item>
            <p>Tubercular meningitis with focal neurological deficits</p>
          </list-item>
          <list-item>
            <p>Systemic amyloidosis</p>
          </list-item>
          <list-item>
            <p>Immune complex glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Bone marrow suppression</p>
          </list-item>
          <list-item>
            <p>Disseminated intravascular coagulation</p>
          </list-item>
        </list>
        <p>Rapid deterioration may occur in the setting of profound immunosuppression, as in HIV infection with low CD4+ counts, immunosuppressant use, and inborn immune conditions.</p>
      </sec>
      <sec id="article-25159.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education and counseling are the cornerstones of&#x000a0;TB management. Proper education materials should be provided to at-risk populations to&#x000a0;reduce bacterial transmission and&#x000a0;enhance the detection of this condition. Patients diagnosed with&#x000a0;TB must be informed about the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>The disease process in relation to the symptoms</p>
          </list-item>
          <list-item>
            <p>Importance of ATT adherence and follow-up</p>
          </list-item>
          <list-item>
            <p>Monitoring for drug toxicity symptoms</p>
          </list-item>
          <list-item>
            <p>Measures&#x000a0;that can help&#x000a0;avoid MTB transmission to close contacts</p>
          </list-item>
        </list>
        <p>Healthcare providers must monitor patients closely for&#x000a0;signs of drug reactions,&#x000a0;progress,&#x000a0;or lack of response to optimize the antitubercular drug regimen.</p>
      </sec>
      <sec id="article-25159.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The most important points to remember when evaluating and managing miliary TB are the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Miliary&#x000a0;TB is a potentially fatal form of disseminated TB&#x000a0;characterized by&#x000a0;millet-seed-like granuloma formation in various organs.</p>
          </list-item>
          <list-item>
            <p>Miliary TB often arises from a primary pulmonary infection that spreads hematogenously. However, extrapulmonary primary sites can also give rise to miliary TB.</p>
          </list-item>
          <list-item>
            <p>The clinical presentation can vary widely. The initial manifestations&#x000a0;may be nonspecific, including fever, weight loss, fatigue, and respiratory symptoms. Diagnosis can be challenging due to the diversity of presentations.</p>
          </list-item>
          <list-item>
            <p>Miliary TB is more common in individuals with poor immunity, such as&#x000a0;people with HIV&#x000a0;or AIDS,&#x000a0;older individuals, and people on immunosuppressive therapy.</p>
          </list-item>
          <list-item>
            <p>Chest x-rays&#x000a0;and CT scans often reveal characteristic miliary patterns, showing widespread, small nodules throughout the lung fields.&#x000a0;However, these imaging features may be absent in early and cryptic miliary TB.</p>
          </list-item>
          <list-item>
            <p>Central nervous system involvement, particularly TBM, can occur and presents a serious and life-threatening complication.</p>
          </list-item>
          <list-item>
            <p>Definitive diagnosis often involves a combination of clinical evaluation, imaging studies, and laboratory tests such as sputum culture, polymerase chain reaction, and Gene Xpert MTB/RIF.</p>
          </list-item>
          <list-item>
            <p>The WHO recommends&#x000a0;the standard antitubercular regimen for patients diagnosed with miliary TB. However, skeletal and neurological involvement can prolong the treatment course.</p>
          </list-item>
          <list-item>
            <p>Treatment adherence is crucial to prevent the development of drug-resistant strains.</p>
          </list-item>
          <list-item>
            <p>Prognosis depends on factors such as the extent of organ involvement, timeliness of diagnosis, and therapeutic effectiveness. Early detection and intervention improve outcomes.</p>
          </list-item>
          <list-item>
            <p>Preventive measures include vaccination with the BCG vaccine in regions where TB is prevalent. Timely detection and treatment of active TB cases also help prevent the development of disseminated TB.</p>
          </list-item>
        </list>
        <p>Miliary&#x000a0;TB is a serious condition requiring prompt medical attention and&#x000a0;diagnostic and&#x000a0;management proficiency.&#x000a0;A comprehensive evaluation&#x000a0;approach&#x000a0;must be pursued&#x000a0;to&#x000a0;initiate the appropriate treatment.</p>
      </sec>
      <sec id="article-25159.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team approach can ensure that patients with miliary TB receive holistic and integrated care to achieve the best possible outcomes. Judicious evaluation by the physicians, gentle bedside care by the nurses, and utmost diligence by laboratory personnel can help treat the disease promptly and stop its spread in the hospital and community. Effective implementation of the WHO's Directly Observed Treatment, Short-Course strategy by community healthcare&#x000a0;personnel&#x000a0;can help ensure treatment adherence. Completion of therapy is vital for disease resolution.</p>
        <p>Specialists who may be involved in the inpatient care of individuals with miliary TB include emergency physicians, pulmonologists, intensivists, gastroenterologists, endocrinologists, neurologists, infectious disease specialists, surgeons, pain specialists, pathologists, and radiologists. The pharmacist can help educate patients about ATT and manage antitubercular medication dosage to prevent drug-induced complications. Nutritionists can help optimize patient nutrition in aid of recovery. Occupational and physical therapists can help patients improve functional independence during recovery.</p>
        <p>Collaboration, shared decision-making, and communication are critical elements for a good outcome. Nothing less than an integrated care pathway and evidence-based diagnostic and management approaches must be rendered to the patient.</p>
      </sec>
      <sec id="article-25159.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25159&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25159">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/miliary-tuberculosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25159">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25159/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25159">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25159.s17">
        <fig id="article-25159.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Miliary Tuberculosis Radiography. This chest x-ray shows millet-shaped lesions in all lung zones, which are features consistent with miliary tuberculosis. Contributed by Katherine Humphreys</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MiliaryTub" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25159.s18">
        <title>References</title>
        <ref id="article-25159.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis: new insights into an old disease.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>7</issue>
            <fpage>415</fpage>
            <page-range>415-30</page-range>
            <pub-id pub-id-type="pmid">15978528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Neff</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis.</article-title>
            <source>Am J Med</source>
            <year>1974</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>494</fpage>
            <page-range>494-505</page-range>
            <pub-id pub-id-type="pmid">4206484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r3">
          <label>3</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tobin</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Tristram</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Tuberculosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">28722945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Tiemersma</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Cobelens</surname>
                <given-names>FGJ</given-names>
              </name>
              <name>
                <surname>Finlay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glaziou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Mirtskhulava</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>HTT</given-names>
              </name>
              <name>
                <surname>Khieu</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>de Haas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Cung</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NV</given-names>
              </name>
            </person-group>
            <article-title>The second national tuberculosis prevalence survey in Vietnam.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>e0232142</fpage>
            <pub-id pub-id-type="pmid">32324806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Pratt</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis - United States, 2019.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2020</year>
            <month>Mar</month>
            <day>20</day>
            <volume>69</volume>
            <issue>11</issue>
            <fpage>286</fpage>
            <page-range>286-289</page-range>
            <pub-id pub-id-type="pmid">32191684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Challenges in the diagnosis &#x00026; treatment of miliary tuberculosis.</article-title>
            <source>Indian J Med Res</source>
            <year>2012</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>703</fpage>
            <page-range>703-30</page-range>
            <pub-id pub-id-type="pmid">22771605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Miliary Tuberculosis.</article-title>
            <source>Microbiol Spectr</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28281441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auerbach</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Acute Generalized Miliary Tuberculosis.</article-title>
            <source>Am J Pathol</source>
            <year>1944</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-36</page-range>
            <pub-id pub-id-type="pmid">19970738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Noronha</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>B&#x000e1;fica</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Barral</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barral-Netto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production.</article-title>
            <source>Pathol Res Pract</source>
            <year>2008</year>
            <volume>204</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <page-range>155-61</page-range>
            <pub-id pub-id-type="pmid">18096327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis and acute respiratory distress syndrome.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>359</fpage>
            <page-range>359-64</page-range>
            <pub-id pub-id-type="pmid">12733492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Pande</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Acute respiratory distress syndrome (ARDS) in miliary tuberculosis: a twelve year experience.</article-title>
            <source>Indian J Chest Dis Allied Sci</source>
            <year>1996</year>
            <season>Jul-Sep</season>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>157</fpage>
            <page-range>157-62</page-range>
            <pub-id pub-id-type="pmid">8987289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ravisankar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Abdominal tuberculosis of the gastrointestinal tract: revisited.</article-title>
            <source>World J Gastroenterol</source>
            <year>2014</year>
            <month>Oct</month>
            <day>28</day>
            <volume>20</volume>
            <issue>40</issue>
            <fpage>14831</fpage>
            <page-range>14831-40</page-range>
            <pub-id pub-id-type="pmid">25356043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasheed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zinicola</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bajwa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Intra-abdominal and gastrointestinal tuberculosis.</article-title>
            <source>Colorectal Dis</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>773</fpage>
            <page-range>773-83</page-range>
            <pub-id pub-id-type="pmid">17868413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramesh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Banait</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Ormerod</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Abdominal tuberculosis in a district general hospital: a retrospective review of 86 cases.</article-title>
            <source>QJM</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-95</page-range>
            <pub-id pub-id-type="pmid">18234735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lam</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2001</year>
            <month>May</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>633</fpage>
            <page-range>633-9</page-range>
            <pub-id pub-id-type="pmid">11380494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pande</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Khilnani</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Clinical profile, laboratory characteristics and outcome in miliary tuberculosis.</article-title>
            <source>QJM</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-37</page-range>
            <pub-id pub-id-type="pmid">7894985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Blumberg</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Musculoskeletal Tuberculosis.</article-title>
            <source>Microbiol Spectr</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28409551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kushwaha</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Neurological complications of miliary tuberculosis.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>112</volume>
            <issue>3</issue>
            <fpage>188</fpage>
            <page-range>188-92</page-range>
            <pub-id pub-id-type="pmid">20031301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slavin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Pollack</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1980</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>352</fpage>
            <page-range>352-66</page-range>
            <pub-id pub-id-type="pmid">7432152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Extrapulmonary tuberculosis.</article-title>
            <source>Indian J Med Res</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>120</volume>
            <issue>4</issue>
            <fpage>316</fpage>
            <page-range>316-53</page-range>
            <pub-id pub-id-type="pmid">15520485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurkan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bosnak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dikici</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bosnak</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yaramis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tas</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Haspolat</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis in children: a clinical review.</article-title>
            <source>Scand J Infect Dis</source>
            <year>1998</year>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>359</fpage>
            <page-range>359-62</page-range>
            <pub-id pub-id-type="pmid">9817515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kadhiravan</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>HIV-TB co-infection: epidemiology, diagnosis &#x00026; management.</article-title>
            <source>Indian J Med Res</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>121</volume>
            <issue>4</issue>
            <fpage>550</fpage>
            <page-range>550-67</page-range>
            <pub-id pub-id-type="pmid">15817963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Proudfoot</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Akhtar</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis in adults.</article-title>
            <source>Br Med J</source>
            <year>1969</year>
            <month>May</month>
            <day>03</day>
            <volume>2</volume>
            <issue>5652</issue>
            <fpage>273</fpage>
            <page-range>273-6</page-range>
            <pub-id pub-id-type="pmid">5780453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Humphries</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cryptic miliary tuberculosis.</article-title>
            <source>Q J Med</source>
            <year>1986</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>228</issue>
            <fpage>421</fpage>
            <page-range>421-8</page-range>
            <pub-id pub-id-type="pmid">3749446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maartens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Willcox</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Benatar</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.</article-title>
            <source>Am J Med</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-6</page-range>
            <pub-id pub-id-type="pmid">2393033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunt</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pettingale</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>The significance of pancytopenia in miliary tuberculosis.</article-title>
            <source>Postgrad Med J</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>63</volume>
            <issue>743</issue>
            <fpage>801</fpage>
            <page-range>801-4</page-range>
            <pub-id pub-id-type="pmid">3444806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shalhoub</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Antoniou</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>The mechanism of hyponatremia in pulmonary tuberculosis.</article-title>
            <source>Ann Intern Med</source>
            <year>1969</year>
            <month>May</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>943</fpage>
            <page-range>943-62</page-range>
            <pub-id pub-id-type="pmid">5769627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Shek</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Severe hypercalcaemia associated with miliary tuberculosis.</article-title>
            <source>J Trop Med Hyg</source>
            <year>1994</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>180</fpage>
            <page-range>180-2</page-range>
            <pub-id pub-id-type="pmid">8007059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGuinness</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Naidich</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Jagirdar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leitman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCauley</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>High resolution CT findings in miliary lung disease.</article-title>
            <source>J Comput Assist Tomogr</source>
            <year>1992</year>
            <season>May-Jun</season>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>384</fpage>
            <page-range>384-90</page-range>
            <pub-id pub-id-type="pmid">1592920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Clinical relevance of ground glass opacity in 105 patients with miliary tuberculosis.</article-title>
            <source>Respir Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>108</volume>
            <issue>6</issue>
            <fpage>924</fpage>
            <page-range>924-30</page-range>
            <pub-id pub-id-type="pmid">24787005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Imaging diagnosis of 12 patients with hepatic tuberculosis.</article-title>
            <source>World J Gastroenterol</source>
            <year>2004</year>
            <month>Jun</month>
            <day>01</day>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>1639</fpage>
            <page-range>1639-42</page-range>
            <pub-id pub-id-type="pmid">15162540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kosaka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kudo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Niino</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.</article-title>
            <source>Chest</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>124</volume>
            <issue>3</issue>
            <fpage>893</fpage>
            <page-range>893-901</page-range>
            <pub-id pub-id-type="pmid">12970014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heysell</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Sifri</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Rehm</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Houpt</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series.</article-title>
            <source>BMC Pulm Med</source>
            <year>2013</year>
            <month>Mar</month>
            <day>21</day>
            <volume>13</volume>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">23514625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ichiya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kuwabara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Akashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Murayama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukumura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>FDG-PET in infectious lesions: The detection and assessment of lesion activity.</article-title>
            <source>Ann Nucl Med</source>
            <year>1996</year>
            <month>May</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>185</fpage>
            <page-range>185-91</page-range>
            <pub-id pub-id-type="pmid">8800447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grieco</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Chmel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Acute disseminated tuberculosis as a diagnostic problem. A clinical study based on twenty-eight cases.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1974</year>
            <month>May</month>
            <volume>109</volume>
            <issue>5</issue>
            <fpage>554</fpage>
            <page-range>554-60</page-range>
            <pub-id pub-id-type="pmid">4823410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munt</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1972</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-55</page-range>
            <pub-id pub-id-type="pmid">5013636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>58</volume>
            <issue>7</issue>
            <fpage>986</fpage>
            <page-range>986-9</page-range>
            <pub-id pub-id-type="pmid">24457341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riquelme</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calvo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salech</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Valderrama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pattillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arellano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arrese</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viviani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Letelier</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>8</issue>
            <fpage>705</fpage>
            <page-range>705-10</page-range>
            <pub-id pub-id-type="pmid">16940883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pande</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion.</article-title>
            <source>Indian J Chest Dis Allied Sci</source>
            <year>2001</year>
            <season>Jul-Sep</season>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>149</fpage>
            <page-range>149-55</page-range>
            <pub-id pub-id-type="pmid">11529433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Banga</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2005</year>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>40</fpage>
            <page-range>40-6</page-range>
            <pub-id pub-id-type="pmid">15756707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tahir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith-Rohrberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of ascitic fluid IFN-gamma and adenosine deaminase assays in the diagnosis of tuberculous ascites.</article-title>
            <source>J Interferon Cytokine Res</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>484</fpage>
            <page-range>484-8</page-range>
            <pub-id pub-id-type="pmid">16800787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rana</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Parbhakar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>424</fpage>
            <page-range>424-30</page-range>
            <pub-id pub-id-type="pmid">20347212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jim&#x000e9;nez Castro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az Nuevo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Rodr&#x000ed;guez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions.</article-title>
            <source>Eur Respir J</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>220</fpage>
            <page-range>220-4</page-range>
            <pub-id pub-id-type="pmid">12608433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reuter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Carstens</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Doubell</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis.</article-title>
            <source>Cardiovasc J S Afr</source>
            <year>2005</year>
            <season>May-Jun</season>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>143</fpage>
            <page-range>143-7</page-range>
            <pub-id pub-id-type="pmid">16049586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Bharat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Debapriya</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baruah</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adenosine Deaminase Levels in CSF of Tuberculous Meningitis Patients.</article-title>
            <source>J Clin Med Res</source>
            <year>2010</year>
            <month>Oct</month>
            <day>11</day>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>220</fpage>
            <page-range>220-4</page-range>
            <pub-id pub-id-type="pmid">21629544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egido</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cubo</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>False positive of ADA determination in cerebrospinal fluid.</article-title>
            <source>Acta Neurol (Napoli)</source>
            <year>1994</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>5-6</issue>
            <fpage>288</fpage>
            <page-range>288-90</page-range>
            <pub-id pub-id-type="pmid">7709800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowdy</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Steingart</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.</article-title>
            <source>PLoS Med</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>e1001074</fpage>
            <pub-id pub-id-type="pmid">21857810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boehme</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Nabeta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hillemann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nicol</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Shenai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krapp</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tahirli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blakemore</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rustomjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Milovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Persing</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ruesch-Gerdes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gotuzzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Rapid molecular detection of tuberculosis and rifampin resistance.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Sep</month>
            <day>09</day>
            <volume>363</volume>
            <issue>11</issue>
            <fpage>1005</fpage>
            <page-range>1005-15</page-range>
            <pub-id pub-id-type="pmid">20825313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schiller</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dendukuri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dheda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Denkinger</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Steingart</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Xpert<sup>&#x000ae;</sup> MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Aug</month>
            <day>27</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD012768</fpage>
            <pub-id pub-id-type="pmid">30148542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ling</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Zwerling</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy.</article-title>
            <source>Expert Rev Respir Med</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>583</fpage>
            <page-range>583-8</page-range>
            <pub-id pub-id-type="pmid">20477293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strumpf</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Sayre</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Re-evaluation of sputum staining for the diagnosis of pulmonary tuberculosis.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1979</year>
            <month>Apr</month>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>599</fpage>
            <page-range>599-602</page-range>
            <pub-id pub-id-type="pmid">87141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stender</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mollerup</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Hongmanee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Godtfredsen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Direct detection and identification of Mycobacterium tuberculosis in smear-positive sputum samples by fluorescence in situ hybridization (FISH) using peptide nucleic acid (PNA) probes.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>9</issue>
            <fpage>830</fpage>
            <page-range>830-7</page-range>
            <pub-id pub-id-type="pmid">10488893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cichero</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piersimoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simonetti</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Gesu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nista</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.</article-title>
            <source>J Clin Microbiol</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>3578</fpage>
            <page-range>3578-82</page-range>
            <pub-id pub-id-type="pmid">10523555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanna</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Bonk</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tick</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Recovery of mycobacteria from blood in mycobacteria growth indicator tube and Lowenstein-Jensen slant after lysis-centrifugation.</article-title>
            <source>J Clin Microbiol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>12</issue>
            <fpage>3315</fpage>
            <page-range>3315-6</page-range>
            <pub-id pub-id-type="pmid">8586725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balada-Llasat</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kamboj</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pancholi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry in the clinical laboratory.</article-title>
            <source>J Clin Microbiol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>51</volume>
            <issue>9</issue>
            <fpage>2875</fpage>
            <page-range>2875-9</page-range>
            <pub-id pub-id-type="pmid">23804379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>LoBue</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Loeffler</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mazurek</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richeldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinnick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Warshauer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Jan</month>
            <day>15</day>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-115</page-range>
            <pub-id pub-id-type="pmid">28052967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nahid</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Alipanah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cattamanchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Grzemska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Higashi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hopewell</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Keshavjee</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lienhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Merrifield</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peloquin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Raftery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saukkonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaaf</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Starke</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Vernon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>63</volume>
            <issue>7</issue>
            <fpage>e147</fpage>
            <page-range>e147-e195</page-range>
            <pub-id pub-id-type="pmid">27516382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hemingway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Innes</surname>
                <given-names>J</given-names>
              </name>
              <collab>British Infection Society</collab>
            </person-group>
            <article-title>British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.</article-title>
            <source>J Infect</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-87</page-range>
            <pub-id pub-id-type="pmid">19643501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cherian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system tuberculosis.</article-title>
            <source>Afr Health Sci</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>116</fpage>
            <page-range>116-27</page-range>
            <pub-id pub-id-type="pmid">21572867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makharia</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Ghoshal</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Ramakrishna</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Agnihotri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Mechenro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pathak</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Intermittent Directly Observed Therapy for Abdominal Tuberculosis: A Multicenter Randomized Controlled Trial Comparing 6 Months Versus 9 Months of Therapy.</article-title>
            <source>Clin Infect Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <day>01</day>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>750</fpage>
            <page-range>750-7</page-range>
            <pub-id pub-id-type="pmid">25969531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Hoang</surname>
                <given-names>TQ</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>QH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Vu</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Stepniewska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>21</day>
            <volume>351</volume>
            <issue>17</issue>
            <fpage>1741</fpage>
            <page-range>1741-51</page-range>
            <pub-id pub-id-type="pmid">15496623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Churchill</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Waters</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Boffito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bower</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Emerson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fidler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khoo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mackie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Monteiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orkin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Palfreeman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pett</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Post</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pozniak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sabin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trevelion</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Winston</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.</article-title>
            <source>HIV Med</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>17 Suppl 4</volume>
            <fpage>s2</fpage>
            <page-range>s2-s104</page-range>
            <pub-id pub-id-type="pmid">27568911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meintjes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lawn</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Scano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maartens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Worodria</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Murdoch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Seyler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van der Loeff</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Reiss</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lynen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Janoff</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Gilks</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Colebunders</surname>
                <given-names>R</given-names>
              </name>
              <collab>International Network for the Study of HIV-associated IRIS</collab>
            </person-group>
            <article-title>Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>516</fpage>
            <page-range>516-23</page-range>
            <pub-id pub-id-type="pmid">18652998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dooley</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rademacher</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature.</article-title>
            <source>Clin Infect Dis</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>872</fpage>
            <page-range>872-87</page-range>
            <pub-id pub-id-type="pmid">9356803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayosi</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Ntsekhe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pandie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gumedze</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pogue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thabane</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smieja</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Joldersma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Awotedu</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Magula</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Naidoo</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Damasceno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chitsa Banda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Manga</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kirenga</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mondo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mntla</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tsitsi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Essop</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hakim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matenga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barasa</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Sani</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Olunuga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ogah</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ansa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aje</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danbauchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ojji</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <collab>IMPI Trial Investigators</collab>
            </person-group>
            <article-title>Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Sep</month>
            <day>18</day>
            <volume>371</volume>
            <issue>12</issue>
            <fpage>1121</fpage>
            <page-range>1121-30</page-range>
            <pub-id pub-id-type="pmid">25178809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devarbhavi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Antituberculous drug-induced liver injury: current perspective.</article-title>
            <source>Trop Gastroenterol</source>
            <year>2011</year>
            <season>Jul-Sep</season>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-74</page-range>
            <pub-id pub-id-type="pmid">22332331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chitty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Ghani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kon</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Dzvova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Hateley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Routledge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.</article-title>
            <source>BMC Infect Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <day>24</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>231</fpage>
            <pub-id pub-id-type="pmid">28340562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalpiaz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Piolanti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cancellieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barozzi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diffuse granulomatous lung disease: combined pathological-HRCT approach.</article-title>
            <source>Radiol Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-63</page-range>
            <pub-id pub-id-type="pmid">24488691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Palayew</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hershfield</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Manfreda</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-8</page-range>
            <pub-id pub-id-type="pmid">9441059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussain</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Irfan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abbasi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anwer</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haqqee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>493</fpage>
            <page-range>493-9</page-range>
            <pub-id pub-id-type="pmid">15141744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bilir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tabak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ozaras</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Senturk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Seyhan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karayel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aktuglu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults.</article-title>
            <source>Respirology</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-24</page-range>
            <pub-id pub-id-type="pmid">11555380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25159.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Guntupalli</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Predictors of development and outcome in patients with acute respiratory distress syndrome due to tuberculosis.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>429</fpage>
            <page-range>429-35</page-range>
            <pub-id pub-id-type="pmid">16602408</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
